Numerous studies in SMA patients and animal models have shown that high SMN levels are vital during the early stages of development (Govoni et al., 2018; Jablonka and Sendtner, 2017; Ramos et al., 2019). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.